ArticlePloS one2026
External validation of the Meggitt-Wagner, Texas University, SINBAD, and Saint Elian classifications for predicting major amputation in patients with diabetes at a public hospital in Peru.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo externally validate and compare the prognostic performance of four diabetic foot ulcer classifications-Meggitt-Wagner, University of Texas, SINBAD, and Saint Elian- for predicting major amputation in patients with diabetes treated at a public hospital in Peru. MATERIALS AND
methodsWe conducted a retrospective cohort study at María Auxiliadora Hospital, one of the few referral centers in Lima with a specialized Diabetic Foot Unit. The study period was January 2015 to December 2019. Eligible patients had a lower-limb ulcer, complete clinical data recorded within 48 hours of the index healthcare encounter (hospital admission or outpatient evaluation), and at least six months of follow-up. Patients with venous ulcers or pressure ulcers related to immobilization were excluded. The primary outcome was major amputation, defined as any procedure above the ankle. Prognostic performance of the four systems was assessed using the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, predictive values, and the Youden index.
resultsA total of 342 patients were included. All had type 2 diabetes mellitus, median age was 62 years (IQR 54-69), and 229 (67.0%) were male. The six-month cumulative incidence of major amputation was 11%. The AUROC values were: Saint Elian, 0.90; University of Texas (3D stage), 0.81; Meggitt-Wagner, 0.81; and SINBAD, 0.74. The most discriminative thresholds were SE ≥ 18, TU stage 3D, MW ≥ 3, and SINBAD ≥5. Patients with SE > 20 had a 32-fold higher risk of amputation compared with those with SE < 16.
conclusionThe Saint Elian and University of Texas systems showed the best prognostic accuracy, while Meggitt-Wagner and SINBAD performed moderately. These findings provide clinicians with clear cut-off points to identify high-risk patients and support early interventions in referral settings. Their effective use depends on multidisciplinary teams trained in diabetic foot management, and selecting the classification system most suited to hospital resources and patient profiles may help reduce amputation rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.